Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
Condition(s):Heart Septal Defects, VentricularLast Updated:June 28, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Heart Septal Defects, VentricularLast Updated:June 28, 2019Completed
Condition(s):Heart Septal Defects, VentricularLast Updated:June 24, 2005Unknown status
Condition(s):Septal Defect, AtrialLast Updated:December 8, 2022Withdrawn
Condition(s):Atrial Septal DefectsLast Updated:June 1, 2018Completed
Condition(s):Atrial Septal DefectLast Updated:April 6, 2023Recruiting
Condition(s):Ventricular Septal DefectLast Updated:September 10, 2019Completed
Condition(s):Ventricular Septal DefectsLast Updated:February 5, 2013Completed
Condition(s):Atrial Septal DefectLast Updated:May 24, 2022Recruiting
Condition(s):Heart Septal Defects, Ventricular; Aortic Valve InsufficiencyLast Updated:September 15, 2005Unknown status
Condition(s):Ventricular Septal DefectLast Updated:September 13, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.